Literature DB >> 19756987

Implication of Th17 and Th1 cells in patients with chronic active hepatitis B.

Jian Ge1, Kai Wang, Qing-Hua Meng, Zhao-Xia Qi, Fan-Li Meng, Yu-Chen Fan.   

Abstract

OBJECTIVE: The pathogenesis of hepatitis B virus (HBV)-associated chronic liver disease is still not fully understood. The immune imbalance of cytokine profile exerts a profound influence on the resolution of HBV infections and HBV clearance. This present study aimed to evaluate the immune status of the peripheral T helper (Th) 17 and Th1 cells in the active patients with chronic HBV infection.
MATERIALS AND METHODS: Thirty patients with chronic active hepatitis B were included in our present study. The frequency of peripheral Th 17 cells (CD3(+)CD8(-)IL-17(+) T cells), Th1 cells (CD3(+)CD8(-)IFN-gamma(+) T cells), and Tc1 cells (CD3(+)CD8(+)IFN-gamma(+) T cells) in chronic hepatitis B (CHB) were analyzed by flow cytometry. The protein and mRNA levels of interleukin-17 (IL-17) and interferon-gamma (IFN-gamma) were measured by enzyme-linked immunosorbent assay and quantitative real-time polymerase chain reaction (PCR).
RESULTS: The percentage of Th17 cells in peripheral blood of CHB patients (1.53 +/- 0.52%) was significantly increased than that in normal controls (0.92 +/- 0.20%; P < 0.05). In contrast, the percentage of Th1 and Tc1 cells of CHB patients was significantly decreased as compared with that of control group. The frequency of Th17 cells had a negative correlation with Th1 cells, and a positive correlation with serum alanine aminotransferase in CHB patients.
CONCLUSION: The elevated peripheral Th17 cells were obtained in the patient with chronic active hepatitis B, suggesting its potential role in the immune activation of chronic HBV infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19756987     DOI: 10.1007/s10875-009-9328-2

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  33 in total

Review 1.  The HLA system. First of two parts.

Authors:  J Klein; A Sato
Journal:  N Engl J Med       Date:  2000-09-07       Impact factor: 91.245

Review 2.  The HLA system. Second of two parts.

Authors:  J Klein; A Sato
Journal:  N Engl J Med       Date:  2000-09-14       Impact factor: 91.245

3.  Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease.

Authors:  W Ray Kim; Steven L Flamm; Adrian M Di Bisceglie; Henry C Bodenheimer
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

Review 4.  T(H)-17 cells in the circle of immunity and autoimmunity.

Authors:  Estelle Bettelli; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2007-04       Impact factor: 25.606

5.  Relationship between serum cytokine levels and histopathological changes of liver in patients with hepatitis B.

Authors:  Nusret Akpolat; Seyfettin Yahsi; Ahmet Godekmerdan; Kutbettin Demirbag; Mehmet Yalniz
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

6.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

Authors:  Ivaylo I Ivanov; Brent S McKenzie; Liang Zhou; Carlos E Tadokoro; Alice Lepelley; Juan J Lafaille; Daniel J Cua; Dan R Littman
Journal:  Cell       Date:  2006-09-22       Impact factor: 41.582

7.  The interleukin-17 pathway is involved in human alcoholic liver disease.

Authors:  Arnaud Lemmers; Christophe Moreno; Thierry Gustot; Raphaël Maréchal; Delphine Degré; Pieter Demetter; Patricia de Nadai; Albert Geerts; Eric Quertinmont; Vincent Vercruysse; Olivier Le Moine; Jacques Devière
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

Review 8.  Interleukin-17 family members and inflammation.

Authors:  Jay K Kolls; Anders Lindén
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

9.  Elevated levels of serum soluble E-selectin in patients with chronic hepatitis B: Correlation with T lymphocyte subsets, NK cells and liver inflammation.

Authors:  Ming-Xian Yan; Hai-Ting Mao; Qian Liu; Wen-Qi Wang; Yan-Qing Li
Journal:  Hepatol Res       Date:  2006-05-02       Impact factor: 4.288

10.  The prevalence of Th17 cells in patients with gastric cancer.

Authors:  Bin Zhang; Guanghua Rong; Huafeng Wei; Meng Zhang; Jianwei Bi; Liye Ma; Xuchao Xue; Guo Wei; Xiaokang Liu; Guoen Fang
Journal:  Biochem Biophys Res Commun       Date:  2008-07-23       Impact factor: 3.575

View more
  49 in total

1.  Increased frequency of circulating Th17 cells in acute-on-chronic hepatitis B liver failure.

Authors:  Li-Yuan Wang; Qing-Hua Meng; Zhi-Qiang Zou; Yu-Chen Fan; Jie Han; Zhao-Xia Qi; Jian Ge; Ai-Ling Xu; Si-Kui Wang; Kai Wang
Journal:  Dig Dis Sci       Date:  2011-10-08       Impact factor: 3.199

2.  New Approaches for Studying Alcoholic Liver Disease.

Authors:  Jun Xu; Xiao Liu; Bin Gao; Michael Karin; Hidekazu Tsukamoto; David Brenner; Tatiana Kisseleva
Journal:  Curr Pathobiol Rep       Date:  2014-09-14

3.  Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines.

Authors:  Dong-Hong Lu; Xiao-Yun Guo; Shan-Yu Qin; Wei Luo; Xiao-Li Huang; Mei Chen; Jia-Xu Wang; Shi-Jia Ma; Xian-Wen Yang; Hai-Xing Jiang
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

Review 4.  Liver inflammation and fibrosis.

Authors:  Yukinori Koyama; David A Brenner
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

Review 5.  Role of Tim-3 in hepatitis B virus infection: An overview.

Authors:  Yuan Liu; Li-Fen Gao; Xiao-Hong Liang; Chun-Hong Ma
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

6.  Changes in circulating Foxp3(+) regulatory T cells and interleukin-17-producing T helper cells during HBV-related acute-on-chronic liver failure.

Authors:  Xue-Song Liang; Cheng-Zhong Li; Yin Zhou; Wei Yin; Ya-Yun Liu; Wen-Han Fan
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

7.  Clinical significance of chronic hepatitis B virus infection in patients with primary Sjögren's syndrome.

Authors:  Ming-Han Chen; Liang-Tsai Hsiao; Ming-Huang Chen; Chang-Youh Tsai; Yi-Hsiang Huang; Chung-Tei Chou
Journal:  Clin Rheumatol       Date:  2011-08-02       Impact factor: 2.980

Review 8.  Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs.

Authors:  Francesca De Nard; Monica Todoerti; Vittorio Grosso; Sara Monti; Silvia Breda; Silvia Rossi; Carlomaurizio Montecucco; Roberto Caporali
Journal:  World J Hepatol       Date:  2015-03-27

Review 9.  Viral (hepatitis C virus, hepatitis B virus, HIV) persistence and immune homeostasis.

Authors:  Yun Zhou; Ying Zhang; Jonathan P Moorman; Zhi Q Yao; Zhan S Jia
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

10.  Interleukin-6 upregulates Th17 response via mTOR/STAT3 pathway in acute-on-chronic hepatitis B liver failure.

Authors:  Hee Yeon Kim; Joo Yeon Jhun; Mi-La Cho; Jong Young Choi; Jae Kyeong Byun; Eun-Kyung Kim; Seung Kew Yoon; Si Hyun Bae; Byung Ha Chung; Chul Woo Yang
Journal:  J Gastroenterol       Date:  2013-12-25       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.